Rhizolutin directly dissociates Aβ and tau aggregates and reduces apoptosis/inflammation related to Alzheimer's disease. (31st December 2021)
- Record Type:
- Journal Article
- Title:
- Rhizolutin directly dissociates Aβ and tau aggregates and reduces apoptosis/inflammation related to Alzheimer's disease. (31st December 2021)
- Main Title:
- Rhizolutin directly dissociates Aβ and tau aggregates and reduces apoptosis/inflammation related to Alzheimer's disease
- Authors:
- Shin, Jisu
Kwon, Yun
Nam, Kwangho
An, Joon Soo
Yang, Seung‐Hoon
Hong, Seong‐Heon
Bae, Munhyung
Moon, Kyuho
Cho, Yakdol
Woo, Jiwan
Park, Keunwan
Kim, Kyeonghwan
Shin, Jongheon
Kim, Byung‐Yong
Kim, YoungSoo
Oh, Dong‐Chan - Abstract:
- Abstract: Background: Alzheimer's disease (AD) is characterized by the aggregation of amyloid‐β (Aβ) and tau, leading to neuronal cell death, neuroinflammation, and brain atrophy. As Aβ and tau aggregates are observed in the brain decades before the onset of cognitive symptoms, clearance of these aggregates has been widely accepted for AD treatments. Method: Through the unbiased screening against the natural product libraries, rhizolutin was selected and its regulatory effects on Aβ and tau aggregation were validated by thioflavin T assays. Clearance of Aβ plaques was observed in APP/PS1 double transgenic AD model mice and subsequent analyses regarding apoptosis and inflammation were conducted using neuronal and glial cell lines. Result: Rhizolutin‐treated AD model mice significantly decreased hippocampal Aβ plaques. Additionally, rhizolutin effectively inhibited the aggregation of Aβ and tau in vitro, more importantly, dissociated both aggregates, thereby reducing Aβ‐induced apoptosis and inflammation in neuronal and glial cells. Conclusion: Our findings reveal that a unique chemical rhizolutin regulates both Aβ and tau at the same time by therapeutic and preventive approaches, representing its novel structure is attractive for AD drug discovery.
- Is Part Of:
- Alzheimer's & dementia. Volume 17(2021)Supplement 9
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 17(2021)Supplement 9
- Issue Display:
- Volume 17, Issue 9 (2021)
- Year:
- 2021
- Volume:
- 17
- Issue:
- 9
- Issue Sort Value:
- 2021-0017-0009-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2021-12-31
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.049661 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25900.xml